http://sns.sunsentinel.com/news/nationworld/sns-cloning.story?coll=sns%2Dnewsnation%2Dheadlines
Published August 8 2001, 6:34 AM
EDT
WASHINGTON -- A group that hopes
to implant cloned embryos in 200 volunteers early next year, and researchers
who say the technique is unsafe, gave conflicting arguments Tuesday before
a scientific panel considering a moratorium on human cloning.
The often-heated debate mirrored
the growing political controversy over cloning. A team led by an Italian
doctor and a U.S. fertility specialist said it would perform the procedures
in an undisclosed Mediterranean nation. Those plans add urgency to a debate
in the U.S. Congress, where the House of Representatives last week passed
a bill that would ban reproductive cloning and the cloning of embryos for
stem cell research.
Several scientists testified on Tuesday
that cloning produces errors in the way the body uses genetic information,
which could result in babies with significant birth defects. Dr. Severino
Antinori, the Italian leader of the cloning team, said his group would
take precautions to avoid severe abnormalities.
Yet Rudolf Jaenisch, a cloning expert
at the Massachusetts Institute of Technology, said current screening methods
would not detect the genetic problems in clones.
"At present there is no way to predict
whether a given clone will develop into a normal or abnormal individual,"
Jaenisch told the National Academy of Sciences panel.
Cloning technology has added complexity
to the question of whether embryonic stem cell research should get federal
funding. Cloned embryos are a potential source of stem cells, which hold
the promise of creating replacement tissue for ailments such as diabetes
and Parkinson's disease.
Most stem cell work relies on embryos
leftover from in vitro fertilization, which many experts consider a less
controversial approach than cloning.
A Massachusetts biotech firm, Advanced
Cell Technology, announced last month that it had begun efforts to make
embryonic human clones for use in stem cell research. Although company
officials said the embryos would not be implanted in a woman's womb and
allowed to develop, such work has spurred calls for a ban on all forms
of human cloning.
In fact, Advanced Cell president
Michael West said his company in the last two years has performed dozens
of experiments in which a cow egg's genetic material was removed and replaced
with DNA from an adult human -- producing an embryonic human clone. The
company's latest experiments are similar, but they use human eggs rather
than cow eggs.
Such research, called therapeutic
cloning, has drawn opposition from abortion opponents and some ethicists
who say it amounts to the exploitation of human life for commercial purposes.
Even many scientists such as Jaenisch
who support therapeutic cloning, however, say it would be too dangerous
to use cloning to make human babies.
In cloning experiments involving
cattle, sheep and mice, only a few percent of cloned animals survive through
gestation to birth, experts say. Those that do survive often are oversized
or suffer from problems with their lungs, brain or kidneys.
Panos Zavos, a Kentucky fertility
specialist working with Antinori's team, got into a shouting match Tuesday
when Jaenisch of MIT asked if he could test cloned human embryos for abnormalities.
Cutting Jaenisch off, Zavos snapped,
"I am not going to let him lecture me."
Many experts say genetic screening
would miss a clone's defects, because cloning might lead even apparently
normal genes to function improperly.
Unlike the genes in sperm, the DNA
in an adult cell is not chemically set to carry out the normal pattern
of embryonic development. Errors in the way that DNA does its job could
lead to severe defects if adult cells are used to clone humans, experts
say.
Still, Antinori's group and another
cloning team said Tuesday that they are moving ahead.
"We will get there," Zavos said.
"It's a matter of determination and we are determined to get there."
After the panel ended, he told a
reporter that the first cloning that he and Antinori would attempt, originally
scheduled for this fall, would not occur until 2002. Both men said they
would only attempt cloning for infertile men and women.
Brigitte Boisselier of the cloning
company Clonaid did not indicate at the panel when her group would make
its cloning attempt, nor would she agree to limit cloning to infertile
men and women. She said society is "changing a lot and science is behind
it. We will be able to use our genes in the way we want."
Clonaid was founded by a French-born
mystic named Rael, whose religion is based on the tenet that aliens created
the human race in a laboratory.
Demand for cloned humans is high,
Boisselier said. Cloning humans is different from cloning animals, she
added. "We could spend 10 to 20 years studying the cloning of sheep and
mice without learning anything about the cloning of humans."
The prospect of human cloning has
motivated many conservative politicians in Washington to try to ban the
practice, but the jury is still out on whether an outright prohibition
will pass both houses of Congress.
By a 265-162 vote, the House of Representatives
voted on July 31 to ban human cloning for both reproductive and research
purposes, but the chances of its passage in the Senate is far from certain.
Two years ago, the Senate refused
to adopt a similar broad prohibition on cloning. It fell 18 votes short
of the necessary 60 votes needed at the time as opponents, including several
top Republicans, argued that it would have shut off embryo research useful
to human health.
President Bush has been deliberating
for months whether to permit federal funding of embryonic stem cell research,
and his aides have said he might make an announcement this month.
Although the White House says the
president's decision will be made on science and not politics, political
factors still loom large. Anti-abortion forces, particularly Catholic voters
the White House has been trying to court, have led the fight against allowing
embryonic stem-cell research.
In the House vote, supporters of
embryo stem-cell research argued for a narrower ban on cloning a human
being while still allowing private companies to create cloned human embryos
for medical purposes. But they lost on a separate vote of 251-176.
The NAS panel that met Tuesday is
slated to issue a report by year's end with recommendations on whether
there should be a moratorium on cloning people.
Tribune staff reporter Jeremy Manier
contributed to this report from Chicago and correspondent William Neikirk
from Washington.
From the Chicago Tribune
By Jeremy Manier and William Neikirk
Tribune staff reporters
Copyright © 2001, The Chicago
Tribune